Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Current, Former US FDA Advisory Committee Members' Reform Idea: Allow Conflicted Experts

Aug 22 2024

• By Sue Sutter

Microphone — • Source: Shutterstock

Related Content

The Wait Is Over: US FDA Advisory Committees Returning To In-Person Meetings Come Fall

Feb 26 2024

US FDA Advisory Committees' Future: Drug-Agnostic Panels, More Debate Time

Feb 22 2023

US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?

Apr 29 2024

Eye On ODAC: Former Members, FDA’s Pazdur Talk Pre-Meeting Mindsets, Impact Of Sponsor’s Experts

Mar 20 2024

Advisory Committees: US FDA Should Explain Divergent Decisions But Keep The Vote

Jun 19 2024

Advisory Committee Consumer Reps Often Fail To Represent Consumer Interests, Groups Tell US FDA

Jun 13 2024

US FDA Advisory Committee Open Public Hearing Changes Urged

Jul 05 2024

Back To White Oak: US FDA Adcomms Go Fully In-Person, Starting With Antimicrobials Panel

Aug 07 2024

Related Companies

Biogen, Inc.

Iterum Therapeutics plc

Additional Topics

United States International Advisory Committees Consumer FDA Drug Review Regulation Drug Approval Standards Manufacturing OTC Drugs Policy Regulatory Research & Development Supply Chain BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window